137 related articles for article (PubMed ID: 17623531)
1. Gonadotrophin products: empowering patients to choose the product that meets their needs.
Weiss N
Reprod Biomed Online; 2007 Jul; 15(1):31-7. PubMed ID: 17623531
[TBL] [Abstract][Full Text] [Related]
2. A questionnaire-based survey to assess patient satisfaction, ease-of-learning, ease-of-use, injection site pain and overall patient satisfaction of the follitropin-alpha (Gonal-f) filled-by-mass (FbM) prefilled pen compared with other systems of gonadotrophin administration.
Utsunomiya T; Tanaka A; Tatsumi K; Ezcurra D
Reprod Biol Endocrinol; 2012 Nov; 10():93. PubMed ID: 23167906
[TBL] [Abstract][Full Text] [Related]
3. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
[TBL] [Abstract][Full Text] [Related]
4. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
Welcker JT; Nawroth F; Bilger W
Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of the administration of follitropin-beta with a pen device.
Bruynesteyn K; Bonsel GJ; Braat DD; Fauser BC; Devroey P; van Genugten ML
Reprod Biomed Online; 2005 Jul; 11(1):26-35. PubMed ID: 16102283
[TBL] [Abstract][Full Text] [Related]
6. Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization.
Dickey RP; Nichols JE; Steinkampf MP; Gocial B; Thornton M; Webster BW; Bello SM; Crain J; Marshall DC;
Reprod Biol Endocrinol; 2003 Oct; 1():63. PubMed ID: 14609434
[TBL] [Abstract][Full Text] [Related]
7. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
Porter R; Kissel C; Saunders H; Keck C
Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
[TBL] [Abstract][Full Text] [Related]
8. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
[TBL] [Abstract][Full Text] [Related]
9. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments.
Pang SC
Expert Rev Med Devices; 2005 Jan; 2(1):27-32. PubMed ID: 16293025
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study.
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
[TBL] [Abstract][Full Text] [Related]
13. Managing infertility with the follitropin alfa prefilled pen injector - patient considerations.
Bühler K
Ther Clin Risk Manag; 2015; 11():995-1001. PubMed ID: 26170678
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
[TBL] [Abstract][Full Text] [Related]
15. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
[TBL] [Abstract][Full Text] [Related]
16. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment.
Jeannerot F; Stüdeli T; Gunther-LaVergne L; Hirning D; Schertz J
Expert Opin Drug Deliv; 2016 Sep; 13(9):1221-9. PubMed ID: 27329677
[TBL] [Abstract][Full Text] [Related]
17. US human factors engineering evaluation of an updated follitropin alfa pen injector (GONAL-f® RFF Redi-ject®) and instructions for use.
Mahony M; Dwyer A; Barkume R; Strochlic A; Jeannerot F; Stüdeli T
Expert Opin Drug Deliv; 2018 Jan; 15(1):5-15. PubMed ID: 29198148
[TBL] [Abstract][Full Text] [Related]
18. Comparison of follitropin β administered by a pen device with follitropin β administered by a conventional syringe in patients undergoing IVF-ET.
Kang HJ; Kim CH; Ahn JW; Lee HA; Kim SH; Chae HD; Kang BM
Clin Exp Reprod Med; 2011 Mar; 38(1):37-41. PubMed ID: 22384416
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy rates in varying age groups after in vitro fertilization: a comparison of follitropin alfa (Gonal F) and follitropin beta (Follistim).
Williams RS; Vensel T; Sistrom CL; Kipersztok S; Rhoton-Vlasak A; Drury K
Am J Obstet Gynecol; 2003 Aug; 189(2):342-6; discussion 346-7. PubMed ID: 14520188
[TBL] [Abstract][Full Text] [Related]
20. A redesigned follitropin alfa pen injector for infertility: results of a market research study.
Abbotts C; Salgado-Braga C; Audibert-Gros C
Patient Prefer Adherence; 2011; 5():315-31. PubMed ID: 21792303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
